Reading Time: < 1 minute The Pfizer company logo displayed at Pfizer Inc. headquarters, in New York, last year. Pfizer‘s new RSV vaccine for older adults may trigger the potentially deadly Guillain-Barre syndrome, the Food and Drug Administration (FDA) has warned. Read More Share